Melissa A. Henderson

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan et al. · Nature · 2017 · 950 citations · Full text

Medicine, Immunology, Oncology +12

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Imran G. House, Peter Savas, Junyun Lai et al. · Clinical Cancer Research · 2019 · 766 citations

Medicine, Immunology, Oncology +17

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Paul A. Beavis, Nicole Milenkovski, Melissa A. Henderson et al. · Cancer Immunology Research · 2015 · 329 citations

Medicine, Immunology, Oncology +17

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida et al. · Journal of Clinical Investigation · 2017 · 321 citations · Full text

Life Sciences, Immunology, Oncology +17

Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity

Junyun Lai, Sherly Mardiana, Imran G. House et al. · Nature Immunology · 2020 · 215 citations

Life Sciences, Immunology, Oncology +17